Deep Genomics

📍 Toronto, Canada🗓 Founded 2014👥 107 employees💰 Last funded 2022
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2014
Founded
Investor geography1 country
United States
3
Investor activity2016–2022 · investors recorded per year
201612019120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Deep Genomics?
Deep Genomics has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Deep Genomics last raise funding?
The most recent investment in Deep Genomics recorded on gritt.io was in 2022.
When was Deep Genomics founded?
Deep Genomics was founded in 2014.
What industry is Deep Genomics in?
Deep Genomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Deep Genomics based?
Deep Genomics is headquartered in Toronto, Canada.